MedPath

ACL Repair and Multimodal Analgesia

Phase 4
Completed
Conditions
Pain
Interventions
Drug: placebo pills and injectables
Registration Number
NCT01868425
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

This study will evaluate the effectiveness of an aggressive multimodal regimen versus standard multimodal for Anterior Cruciate Ligament (ACL) repair using hamstring graft for patients having surgery in our outpatient surgicenter.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
112
Inclusion Criteria
  • Patients of orthopedic surgeons on the study team scheduled for ACL repair using hamstring graft from the same leg will be considered for inclusion in this study. Other inclusion criteria are as follows:

    • American Society of Anesthesiologists (ASA) physical status 1-3
    • BMI of < 40 kg/m2
    • Consents to general anesthesia and pre-operative femoral nerve block for case
Exclusion Criteria
  • Any contraindication to a femoral nerve block
  • Allergy to local anesthetics, nonsteroidal anti-inflammatory medications, ketamine, acetaminophen, hydromorphone, oxycodone
  • Peripheral or central nervous system disease
  • Renal or hepatic impairment
  • History of opioid dependence or current regular narcotic use
  • Significant psychiatric disease
  • Pregnancy or lactation (by verbal report)
  • Seizure Disorder
  • History of post-operative nausea and vomiting
  • Latex allergy
  • Clinically significant cardiac or pulmonary disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
placebo pills and injectablesplacebo pills and injectablesstandard care which includes ketorolac, bupivacaine, fentanyl, ondansetron, dexamethasone, sevoflurane
Primary Outcome Measures
NameTimeMethod
Opioid Consumption in the Immediate Postoperative PeriodUp to 10 hours

This data will be entered into the participants electronic medical record and collected from their chart once the participant has been discharged. The "immediate postoperative period" covers the participant's entire time in the outpatient surgery center after they have entered the recovery room postoperatively. The amount of time they remain in the outpatient surgery center postoperatively varies from a minimum of 1 hour to a maximum of 10 hours and an average of 4 hours.

Secondary Outcome Measures
NameTimeMethod
Post-Operative Incidence of NauseaUp to 24 hours following surgery

Incidence of nausea as recorded in the electronic medical record (EMR) in the recovery room through the first 24-hrs post-op.

Incidence of Post-Operative PruritusUp to 24 hours following surgery

Pruritus in recovery and through the first 24 hours post-op.

Sedation ScaleUp to 24 hours following surgery

Sedation scale measured in recovery room, 1-hr post op, and 24 hrs op. The Sedation Scale is scored from 0-10 where 0 = normal, no sleepier than average, 10 = sleepy, hard to stay awake.

Pain Scores During Recoveryup to 24 hours postoperatively

Pain scores during recovery period through the first 24 hours of recovery, recorded upon arrival to recovery room, 1-hr post-op, 24-hrs post-op. This outcome reports lowest and highest pain score since discharge to 24 hour phone call. Pain scores are collected verbally on a scale of 0-10 where 10 is the most severe pain.

Post-Operative Pruritis ScoreUp to 24 hours following surgery

Participants will be asked to rate their pruritis on a scale of 0 (no itching) - 10 (worst itchiness) while in post-op recovery room and then at 24 hours post-op via phone call.

Intraoperative Medication Use: FentanylFrom induction until arrival in post anesthesia care unit.

All participants received standard induction medications.

Intraoperative Medication Use: Ketorolac and LidocaineFrom induction until arrival in post anesthesia care unit.

All participants received standard induction medications.

Number of Participants Who Received Medication for NauseaUp to 24 hours following surgery

Number of participant who received medication for nausea prior to discharge and after discharge, up to 24 hours post-op.

Post-Operative Nausea ScoresUp to 24 hours following surgery

Nausea scores will be collected in post-operative recovery and 24 hours later (via phone). The participant will be asked to rate their nausea on a scale of 0 (no nausea) - 10 (worst possible).

Impact of Block Characteristics on Pain ControlUp to 24 hours following surgery
Number of Participants With Complications From the ProcedureUp to 24 hours following surgery
Time to DischargeUp to 24 hours following surgery

Time to discharge from the recovery room (Phase I recovery) and the outpatient surgery center (Phase II recovery).

Trial Locations

Locations (1)

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath